These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8053493)
1. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. Latres E; Drobnjak M; Pollack D; Oliva MR; Ramos M; Karpeh M; Woodruff JM; Cordon-Cardo C Am J Pathol; 1994 Aug; 145(2):345-55. PubMed ID: 8053493 [TBL] [Abstract][Full Text] [Related]
2. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456 [TBL] [Abstract][Full Text] [Related]
3. p53 abnormalities in different subtypes of human sarcomas. Andreassen A; Oyjord T; Hovig E; Holm R; Flørenes VA; Nesland JM; Myklebost O; Høie J; Bruland OS; Børresen AL Cancer Res; 1993 Feb; 53(3):468-71. PubMed ID: 8425179 [TBL] [Abstract][Full Text] [Related]
4. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343 [TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262 [TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310 [TBL] [Abstract][Full Text] [Related]
7. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948 [TBL] [Abstract][Full Text] [Related]
8. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. Pollock RE; Lang A; Luo J; El-Naggar AK; Yu D Oncogene; 1996 May; 12(9):2035-9. PubMed ID: 8649865 [TBL] [Abstract][Full Text] [Related]
9. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351 [TBL] [Abstract][Full Text] [Related]
10. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563 [TBL] [Abstract][Full Text] [Related]
11. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Jhanwar SC; Chen Q; Li FP; Brennan MF; Woodruff JM Cancer Genet Cytogenet; 1994 Dec; 78(2):138-44. PubMed ID: 7828144 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152 [TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy. Schneider-Stock R; Radig K; Oda Y; Mellin W; Rys J; Niezabitowski A; Roessner A J Cancer Res Clin Oncol; 1997; 123(4):211-8. PubMed ID: 9177493 [TBL] [Abstract][Full Text] [Related]
14. Chromosome changes in soft tissue sarcomas. Becher R; Wake N; Gibas Z; Ochi H; Sandberg AA J Natl Cancer Inst; 1984 Apr; 72(4):823-31. PubMed ID: 6323809 [TBL] [Abstract][Full Text] [Related]
15. TP53 in bone and soft tissue sarcomas. Thoenen E; Curl A; Iwakuma T Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma. Thorlacius S; Jonasdottir O; Eyfjord JE Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906 [TBL] [Abstract][Full Text] [Related]
17. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP. Oliva MR; Saez GT; Latres E; Cordon-Cardo C Diagn Mol Pathol; 1995 Mar; 4(1):54-8. PubMed ID: 7735557 [TBL] [Abstract][Full Text] [Related]
18. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers. Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas. Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]